MOUNTAIN VIEW, Calif. — November 19, 2025 — Leads & Copy — Heartflow, Inc. (HTFL), a leader in artificial intelligence (AI) for coronary artery disease (CAD), announced that management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 12:30 p.m. PT / 3:30 p.m. ET.
A live and archived version of the fireside chat will be available in the Investor Relations section of the Heartflow website.
Heartflow’s technology is redefining precision cardiovascular care through clinically-proven AI and the world’s largest coronary imaging dataset. The technology has been adopted by more than 1,400 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution widely available to a diverse patient population.
Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 600 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 500,000 patients worldwide.
Key benefits of Heartflow’s technology include:
A proprietary data pipeline built from more than 110 million annotated CTA images powers advanced AI models that deliver accurate, reproducible insights across diverse patient populations.
Extensive clinical and real-world validation through clinical evidence in over 100 studies assessing over 365,000 patients.
Proven real-world practice with reproducibility and accuracy, and coronary CTA image acceptance rates exceed 96%.
Seamless clinical integration via upgraded workflow delivers final quality-reviewed analyses instantly upon order, enabling clinicians to move from diagnosis to decision without delay.
Heartflow meets or exceeds leading international standards for quality system, global security and patient-data integrity compliance, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001.
Heartflow is transforming coronary artery disease from the world’s leading cause of death into a condition that can be detected early, diagnosed accurately, and managed for life. The Heartflow One platform uses AI to turn coronary CTA images into personalized 3D models of the heart, providing clinically meaningful, actionable insights into plaque location, volume, and composition and its effect on blood flow — all without invasive procedures.
Investor Contact:
Nick Laudico
nlaudico@heartflow.com
Media Contact:
Elliot Levy
elevy@heartflow.com
Source: Heartflow, Inc.
